Stonvex publishes market data and research only. Not investment advice. Not a registered investment advisor. Read disclaimer.

ATRC

Live52w low +10.2%

Annual Quarterly

Core line items from ATRC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.

Log in Get Started

Annual Quarterly

Entity: AtriCure, Inc.·Source: SEC EDGAR companyfacts·Next-Q consensus from Finnhub

Metric	Q3 2026 (Est.) Expected 2026-07-27	Q1 2026 2026-03-31	Annual 2025 2025-12-31	Q3 2025 2025-09-30	Q2 2025 2025-06-30
Revenue	$155.09M	$141.25M	$534.53M	$394.03M	$259.76M
Operating Income	Not available	$526.00K	$-9.45M	$-11.94M	$-12.15M
Net Income	Not available	$108.00K	$-11.45M	$-13.20M	$-12.94M
EPS (Diluted)	$0.01	$0.00	$-0.24	$-0.28	$-0.27
Total Assets	Not available	$643.99M	$654.18M	$635.44M	$608.85M
Total Liabilities	Not available	$152.29M	$162.24M	$158.94M	$144.36M
Cash & Equivalents	Not available	$146.16M	$167.43M	$147.87M	$117.80M
Free Cash Flow OCF − CapEx	Not available	$-7.85M	$48.28M	$29.86M	$5.75M
Shares Outstanding	Not available	50.63M	49.79M	49.71M	49.69M

Financial data is sourced from public SEC filings where available. Some metrics may be unavailable without premium market data. The amber (Est.) column shows Wall Street analyst consensus for the next reporting period — only Revenue and EPS are covered by published consensus, so other line items remain blank. These are third-party estimates, not company guidance.

Core line items from ATRC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.

52w low +10.2%

Entity: AtriCure, Inc.·Source: SEC EDGAR companyfacts·Next-Q consensus from Finnhub

Metric	Q3 2026 (Est.) Expected 2026-07-27	Q1 2026 2026-03-31	Annual 2025 2025-12-31	Q3 2025 2025-09-30	Q2 2025 2025-06-30
Revenue	$155.09M	$141.25M	$534.53M	$394.03M	$259.76M
Operating Income	Not available	$526.00K	$-9.45M	$-11.94M	$-12.15M
Net Income	Not available	$108.00K	$-11.45M	$-13.20M	$-12.94M
EPS (Diluted)	$0.01	$0.00	$-0.24	$-0.28	$-0.27
Total Assets	Not available	$643.99M	$654.18M	$635.44M	$608.85M
Total Liabilities	Not available	$152.29M	$162.24M	$158.94M	$144.36M
Cash & Equivalents	Not available	$146.16M	$167.43M	$147.87M	$117.80M
Free Cash Flow OCF − CapEx	Not available	$-7.85M	$48.28M	$29.86M	$5.75M
Shares Outstanding	Not available	50.63M	49.79M	49.71M	49.69M

Financial data is sourced from public SEC filings where available. Some metrics may be unavailable without premium market data. The amber (Est.) column shows Wall Street analyst consensus for the next reporting period — only Revenue and EPS are covered by published consensus, so other line items remain blank. These are third-party estimates, not company guidance.